Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00295932 · ADVERSE EVENTS

Adverse events

Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma · Source last updated 2018-11-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
1 year
Other-event reporting threshold
5%
Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
1.3 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide

Phase I Weekly 1.3 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide

0 / 44 / 43 / 4
1.6 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide

Phase I Weekly 1.6 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide

3 / 66 / 66 / 6
1.6 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide

Phase I Weekly 1.6 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide

2 / 33 / 32 / 3
1.8 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide

Phase I Weekly 1.8 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide

2 / 44 / 43 / 4
Dose Level 1- 1.0 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamid

Phase I Twice Weekly 1.0 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide

0 / 22 / 21 / 2
Dose Level 2 - 1.3 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamid

Phase I Twice Weekly 1.3 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide

5 / 1818 / 1813 / 18
Dose Level 3 - 1.3 mg/m2 Bortezomib; 1000 mg/m2 Cyclophospham

Phase I Twice Weekly 1.3 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide

1 / 33 / 32 / 3
Dose Level 4 - 1.5 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphami

Phase I Twice Weekly 1.5 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide

2 / 44 / 43 / 4
Dose Level 5 - 1.3 mg/m2 Bortezomib; 1000 mg/m2 Cyclophospham

Phase I Twice Weekly 1.3 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide; Pegylated G-CSF

1 / 1010 / 107 / 10
Weekly Bortezomib Dosing Schedule

Phase II Randomized Weekly bortezomib dosing schedule

4 / 1212 / 124 / 12
Twice-weekly Bortezomib Dosing Schedule

Phase II Randomized Twice-weekly bortezomib dosing schedule

8 / 1313 / 135 / 13

Group identifiers: EG000: 1.3 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide · EG001: 1.6 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide · EG002: 1.6 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide · EG003: 1.8 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide · EG004: Dose Level 1- 1.0 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamid · EG005: Dose Level 2 - 1.3 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamid · EG006: Dose Level 3 - 1.3 mg/m2 Bortezomib; 1000 mg/m2 Cyclophospham · EG007: Dose Level 4 - 1.5 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphami · EG008: Dose Level 5 - 1.3 mg/m2 Bortezomib; 1000 mg/m2 Cyclophospham · EG009: Weekly Bortezomib Dosing Schedule · EG010: Twice-weekly Bortezomib Dosing Schedule

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Musculoskeletal and connective tissue disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Arthritis
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      1
      num At Risk
      13
    term
    Atrial fibrillation
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Metabolism and nutrition disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Dehydration
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      1
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      1
      num At Risk
      13
    term
    Diarrhea
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      3
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      2
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      2
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      1
      num At Risk
      13
    term
    Febrile neutropenia
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Respiratory, thoracic and mediastinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      3
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      1
      num At Risk
      13
    term
    Dyspnea
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Fever
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      1
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Hemorrhage/Bleeding, other
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Injury, poisoning and procedural complications
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      1
      num At Risk
      13
    term
    Hemorrhage/Bleeding assoc w/surg, intra/ post-op
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Respiratory, thoracic and mediastinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      1
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      1
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Hypoxia
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Infections and infestations
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Pneumonia
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Infections and infestations
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      1
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Cellulitis

Other reported adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    stats
    1. group Id
      EG000
      num Affected
      2
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      3
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      2
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      1
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      12
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      2
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Constipation
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      2
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      3
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      3
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      2
      num At Risk
      13
    term
    Diarrhea
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      2
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      3
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      2
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      2
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      10
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      4
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      2
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      2
      num At Risk
      13
    term
    Fatigue
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Metabolism and nutrition disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      2
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      4
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      6
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      3
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      3
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      5
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      5
      num At Risk
      13
    term
    Hyperglycemia
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Metabolism and nutrition disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      2
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      3
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      2
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      3
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      2
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      3
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      6
      num At Risk
      13
    term
    Hypocalcemia
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Metabolism and nutrition disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      2
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      2
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      2
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      5
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      3
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      6
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      2
      num At Risk
      13
    term
    Hypophosphatemia
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Investigations
    stats
    1. group Id
      EG000
      num Affected
      3
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      4
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      2
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      3
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      2
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      15
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      3
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      4
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      9
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      10
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      10
      num At Risk
      13
    term
    Lymphocyte count decreased
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      2
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      3
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      3
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Nausea
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Nervous system disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      2
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      10
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      2
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      3
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      1
      num At Risk
      13
    term
    Peripheral sensory neuropathy
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Investigations
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      3
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      4
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      2
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      8
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      2
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      2
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      4
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      5
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      10
      num At Risk
      13
    term
    Platelet count decreased
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      5
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      2
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      4
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      8
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      2
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      2
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      5
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      8
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      8
      num At Risk
      13
    term
    Anemia
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Respiratory, thoracic and mediastinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      4
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      2
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Dyspnea
Complete source fields
event Groups
  1. deaths Num Affected
    3
    deaths Num At Risk
    4
    description
    Phase I Weekly 1.3 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide
    id
    EG000
    other Num Affected
    4
    other Num At Risk
    4
    serious Num Affected
    0
    serious Num At Risk
    4
    title
    1.3 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide
  2. deaths Num Affected
    6
    deaths Num At Risk
    6
    description
    Phase I Weekly 1.6 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide
    id
    EG001
    other Num Affected
    6
    other Num At Risk
    6
    serious Num Affected
    3
    serious Num At Risk
    6
    title
    1.6 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide
  3. deaths Num Affected
    2
    deaths Num At Risk
    3
    description
    Phase I Weekly 1.6 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide
    id
    EG002
    other Num Affected
    3
    other Num At Risk
    3
    serious Num Affected
    2
    serious Num At Risk
    3
    title
    1.6 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide
  4. deaths Num Affected
    3
    deaths Num At Risk
    4
    description
    Phase I Weekly 1.8 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide
    id
    EG003
    other Num Affected
    4
    other Num At Risk
    4
    serious Num Affected
    2
    serious Num At Risk
    4
    title
    1.8 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide
  5. deaths Num Affected
    1
    deaths Num At Risk
    2
    description
    Phase I Twice Weekly 1.0 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide
    id
    EG004
    other Num Affected
    2
    other Num At Risk
    2
    serious Num Affected
    0
    serious Num At Risk
    2
    title
    Dose Level 1- 1.0 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamid
  6. deaths Num Affected
    13
    deaths Num At Risk
    18
    description
    Phase I Twice Weekly 1.3 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide
    id
    EG005
    other Num Affected
    18
    other Num At Risk
    18
    serious Num Affected
    5
    serious Num At Risk
    18
    title
    Dose Level 2 - 1.3 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamid
  7. deaths Num Affected
    2
    deaths Num At Risk
    3
    description
    Phase I Twice Weekly 1.3 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide
    id
    EG006
    other Num Affected
    3
    other Num At Risk
    3
    serious Num Affected
    1
    serious Num At Risk
    3
    title
    Dose Level 3 - 1.3 mg/m2 Bortezomib; 1000 mg/m2 Cyclophospham
  8. deaths Num Affected
    3
    deaths Num At Risk
    4
    description
    Phase I Twice Weekly 1.5 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide
    id
    EG007
    other Num Affected
    4
    other Num At Risk
    4
    serious Num Affected
    2
    serious Num At Risk
    4
    title
    Dose Level 4 - 1.5 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphami
  9. deaths Num Affected
    7
    deaths Num At Risk
    10
    description
    Phase I Twice Weekly 1.3 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide; Pegylated G-CSF
    id
    EG008
    other Num Affected
    10
    other Num At Risk
    10
    serious Num Affected
    1
    serious Num At Risk
    10
    title
    Dose Level 5 - 1.3 mg/m2 Bortezomib; 1000 mg/m2 Cyclophospham
  10. deaths Num Affected
    4
    deaths Num At Risk
    12
    description
    Phase II Randomized Weekly bortezomib dosing schedule
    id
    EG009
    other Num Affected
    12
    other Num At Risk
    12
    serious Num Affected
    4
    serious Num At Risk
    12
    title
    Weekly Bortezomib Dosing Schedule
  11. deaths Num Affected
    5
    deaths Num At Risk
    13
    description
    Phase II Randomized Twice-weekly bortezomib dosing schedule
    id
    EG010
    other Num Affected
    13
    other Num At Risk
    13
    serious Num Affected
    8
    serious Num At Risk
    13
    title
    Twice-weekly Bortezomib Dosing Schedule
frequency Threshold
5
other Events
  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    stats
    1. group Id
      EG000
      num Affected
      2
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      3
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      2
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      1
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      12
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      2
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Constipation
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      2
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      3
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      3
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      2
      num At Risk
      13
    term
    Diarrhea
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      2
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      3
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      2
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      2
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      10
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      4
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      2
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      2
      num At Risk
      13
    term
    Fatigue
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Metabolism and nutrition disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      2
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      4
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      6
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      3
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      3
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      5
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      5
      num At Risk
      13
    term
    Hyperglycemia
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Metabolism and nutrition disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      2
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      3
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      2
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      3
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      2
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      3
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      6
      num At Risk
      13
    term
    Hypocalcemia
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Metabolism and nutrition disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      2
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      2
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      2
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      5
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      3
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      6
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      2
      num At Risk
      13
    term
    Hypophosphatemia
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Investigations
    stats
    1. group Id
      EG000
      num Affected
      3
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      4
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      2
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      3
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      2
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      15
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      3
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      4
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      9
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      10
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      10
      num At Risk
      13
    term
    Lymphocyte count decreased
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      2
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      3
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      3
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Nausea
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Nervous system disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      2
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      10
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      2
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      3
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      1
      num At Risk
      13
    term
    Peripheral sensory neuropathy
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Investigations
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      3
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      4
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      2
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      8
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      2
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      2
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      4
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      5
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      10
      num At Risk
      13
    term
    Platelet count decreased
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      5
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      2
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      4
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      8
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      2
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      2
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      5
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      8
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      8
      num At Risk
      13
    term
    Anemia
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Respiratory, thoracic and mediastinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      4
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      2
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Dyspnea
serious Events
  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Musculoskeletal and connective tissue disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Arthritis
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      1
      num At Risk
      13
    term
    Atrial fibrillation
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Metabolism and nutrition disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Dehydration
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      1
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      1
      num At Risk
      13
    term
    Diarrhea
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      3
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      2
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      2
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      1
      num At Risk
      13
    term
    Febrile neutropenia
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Respiratory, thoracic and mediastinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      3
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      1
      num At Risk
      13
    term
    Dyspnea
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Fever
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      1
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Hemorrhage/Bleeding, other
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Injury, poisoning and procedural complications
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      1
      num At Risk
      13
    term
    Hemorrhage/Bleeding assoc w/surg, intra/ post-op
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Respiratory, thoracic and mediastinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      1
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      1
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Hypoxia
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Infections and infestations
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Pneumonia
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Infections and infestations
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      4
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      6
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      4
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      2
    6. group Id
      EG005
      num Affected
      1
      num At Risk
      18
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      4
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      10
    10. group Id
      EG009
      num Affected
      0
      num At Risk
      12
    11. group Id
      EG010
      num Affected
      0
      num At Risk
      13
    term
    Cellulitis
time Frame
1 year

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice